CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in consumers’ desire to control their health
3.4.1.2. Digitization of consumer healthcare business
3.4.1.3. Rise in awareness about personal healthcare and increase in geriatric population
3.4.2. Restraints
3.4.2.1. The stringent government regulations
3.4.3. Opportunities
3.4.3.1. Latest startups in consumer healthcare market and development of customized products
3.5. COVID-19 Impact Analysis on the market
3.6. Average Selling Price
CHAPTER 4: CONSUMER HEALTHCARE MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. OTC Pharmaceuticals
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Personal Care Products
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Dietary Supplements
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL
5.1. Overview
5.1.1. Market size and forecast
5.2. Online
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Offline
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.3.4. Offline Consumer Healthcare Market by Type
CHAPTER 6: CONSUMER HEALTHCARE MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key trends and opportunities
6.2.2. Market size and forecast, by Product
6.2.3. Market size and forecast, by Distribution Channel
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Key market trends, growth factors and opportunities
6.2.4.1.2. Market size and forecast, by Product
6.2.4.1.3. Market size and forecast, by Distribution Channel
6.2.4.2. Canada
6.2.4.2.1. Key market trends, growth factors and opportunities
6.2.4.2.2. Market size and forecast, by Product
6.2.4.2.3. Market size and forecast, by Distribution Channel
6.2.4.3. Mexico
6.2.4.3.1. Key market trends, growth factors and opportunities
6.2.4.3.2. Market size and forecast, by Product
6.2.4.3.3. Market size and forecast, by Distribution Channel
6.3. Europe
6.3.1. Key trends and opportunities
6.3.2. Market size and forecast, by Product
6.3.3. Market size and forecast, by Distribution Channel
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Key market trends, growth factors and opportunities
6.3.4.1.2. Market size and forecast, by Product
6.3.4.1.3. Market size and forecast, by Distribution Channel
6.3.4.2. France
6.3.4.2.1. Key market trends, growth factors and opportunities
6.3.4.2.2. Market size and forecast, by Product
6.3.4.2.3. Market size and forecast, by Distribution Channel
6.3.4.3. UK
6.3.4.3.1. Key market trends, growth factors and opportunities
6.3.4.3.2. Market size and forecast, by Product
6.3.4.3.3. Market size and forecast, by Distribution Channel
6.3.4.4. Italy
6.3.4.4.1. Key market trends, growth factors and opportunities
6.3.4.4.2. Market size and forecast, by Product
6.3.4.4.3. Market size and forecast, by Distribution Channel
6.3.4.5. Spain
6.3.4.5.1. Key market trends, growth factors and opportunities
6.3.4.5.2. Market size and forecast, by Product
6.3.4.5.3. Market size and forecast, by Distribution Channel
6.3.4.6. Rest of Europe
6.3.4.6.1. Key market trends, growth factors and opportunities
6.3.4.6.2. Market size and forecast, by Product
6.3.4.6.3. Market size and forecast, by Distribution Channel
6.4. Asia-Pacific
6.4.1. Key trends and opportunities
6.4.2. Market size and forecast, by Product
6.4.3. Market size and forecast, by Distribution Channel
6.4.4. Market size and forecast, by country
6.4.4.1. China
6.4.4.1.1. Key market trends, growth factors and opportunities
6.4.4.1.2. Market size and forecast, by Product
6.4.4.1.3. Market size and forecast, by Distribution Channel
6.4.4.2. Japan
6.4.4.2.1. Key market trends, growth factors and opportunities
6.4.4.2.2. Market size and forecast, by Product
6.4.4.2.3. Market size and forecast, by Distribution Channel
6.4.4.3. India
6.4.4.3.1. Key market trends, growth factors and opportunities
6.4.4.3.2. Market size and forecast, by Product
6.4.4.3.3. Market size and forecast, by Distribution Channel
6.4.4.4. Australia
6.4.4.4.1. Key market trends, growth factors and opportunities
6.4.4.4.2. Market size and forecast, by Product
6.4.4.4.3. Market size and forecast, by Distribution Channel
6.4.4.5. South Korea
6.4.4.5.1. Key market trends, growth factors and opportunities
6.4.4.5.2. Market size and forecast, by Product
6.4.4.5.3. Market size and forecast, by Distribution Channel
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Key market trends, growth factors and opportunities
6.4.4.6.2. Market size and forecast, by Product
6.4.4.6.3. Market size and forecast, by Distribution Channel
6.5. LAMEA
6.5.1. Key trends and opportunities
6.5.2. Market size and forecast, by Product
6.5.3. Market size and forecast, by Distribution Channel
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Key market trends, growth factors and opportunities
6.5.4.1.2. Market size and forecast, by Product
6.5.4.1.3. Market size and forecast, by Distribution Channel
6.5.4.2. Saudi Arabia
6.5.4.2.1. Key market trends, growth factors and opportunities
6.5.4.2.2. Market size and forecast, by Product
6.5.4.2.3. Market size and forecast, by Distribution Channel
6.5.4.3. South Africa
6.5.4.3.1. Key market trends, growth factors and opportunities
6.5.4.3.2. Market size and forecast, by Product
6.5.4.3.3. Market size and forecast, by Distribution Channel
6.5.4.4. Rest of LAMEA
6.5.4.4.1. Key market trends, growth factors and opportunities
6.5.4.4.2. Market size and forecast, by Product
6.5.4.4.3. Market size and forecast, by Distribution Channel
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2022
CHAPTER 8: COMPANY PROFILES
8.1. Johnson & Johnson
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. Sanofi S.A.
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.3. Pfizer Inc.
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.4. Abbott Laboratories
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.5. GlaxoSmithKline plc
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.7. Teva Pharmaceutical Industries Limited
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.8. Amway Corp.
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.9. Bayer AG
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business performance
8.10. BASF SE
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business performance
TABLE 01. GLOBAL CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 02. CONSUMER HEALTHCARE MARKET FOR OTC PHARMACEUTICALS, BY REGION, 2022-2032 ($MILLION)
TABLE 03. CONSUMER HEALTHCARE MARKET FOR PERSONAL CARE PRODUCTS, BY REGION, 2022-2032 ($MILLION)
TABLE 04. CONSUMER HEALTHCARE MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2022-2032 ($MILLION)
TABLE 05. GLOBAL CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 06. CONSUMER HEALTHCARE MARKET FOR ONLINE, BY REGION, 2022-2032 ($MILLION)
TABLE 07. CONSUMER HEALTHCARE MARKET FOR OFFLINE, BY REGION, 2022-2032 ($MILLION)
TABLE 08. GLOBAL OFFLINE CONSUMER HEALTHCARE MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 09. CONSUMER HEALTHCARE MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 10. NORTH AMERICA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 11. NORTH AMERICA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 12. NORTH AMERICA CONSUMER HEALTHCARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 13. U.S. CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 14. U.S. CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 15. CANADA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 16. CANADA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 17. MEXICO CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 18. MEXICO CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 19. EUROPE CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 20. EUROPE CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 21. EUROPE CONSUMER HEALTHCARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 22. GERMANY CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 23. GERMANY CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 24. FRANCE CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 25. FRANCE CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 26. UK CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 27. UK CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 28. ITALY CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 29. ITALY CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 30. SPAIN CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 31. SPAIN CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 32. REST OF EUROPE CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 33. REST OF EUROPE CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 34. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 35. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 36. ASIA-PACIFIC CONSUMER HEALTHCARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 37. CHINA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 38. CHINA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 39. JAPAN CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 40. JAPAN CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 41. INDIA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 42. INDIA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 43. AUSTRALIA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 44. AUSTRALIA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 45. SOUTH KOREA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 46. SOUTH KOREA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 47. REST OF ASIA-PACIFIC CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 48. REST OF ASIA-PACIFIC CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 49. LAMEA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 50. LAMEA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 51. LAMEA CONSUMER HEALTHCARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 52. BRAZIL CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 53. BRAZIL CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 54. SAUDI ARABIA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 55. SAUDI ARABIA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 56. SOUTH AFRICA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 57. SOUTH AFRICA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 58. REST OF LAMEA CONSUMER HEALTHCARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 59. REST OF LAMEA CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 60. JOHNSON & JOHNSON: KEY EXECUTIVES
TABLE 61. JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 62. JOHNSON & JOHNSON: PRODUCT SEGMENTS
TABLE 63. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 64. JOHNSON & JOHNSON: KEY STRATERGIES
TABLE 65. SANOFI S.A.: KEY EXECUTIVES
TABLE 66. SANOFI S.A.: COMPANY SNAPSHOT
TABLE 67. SANOFI S.A.: PRODUCT SEGMENTS
TABLE 68. SANOFI S.A.: PRODUCT PORTFOLIO
TABLE 69. PFIZER INC.: KEY EXECUTIVES
TABLE 70. PFIZER INC.: COMPANY SNAPSHOT
TABLE 71. PFIZER INC.: PRODUCT SEGMENTS
TABLE 72. PFIZER INC.: PRODUCT PORTFOLIO
TABLE 73. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 74. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 75. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 76. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 77. GLAXOSMITHKLINE PLC: KEY EXECUTIVES
TABLE 78. GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT
TABLE 79. GLAXOSMITHKLINE PLC: PRODUCT SEGMENTS
TABLE 80. GLAXOSMITHKLINE PLC: PRODUCT PORTFOLIO
TABLE 81. GLAXOSMITHKLINE PLC: KEY STRATERGIES
TABLE 82. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: KEY EXECUTIVES
TABLE 83. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT
TABLE 84. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT SEGMENTS
TABLE 85. BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT PORTFOLIO
TABLE 86. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: KEY EXECUTIVES
TABLE 87. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: COMPANY SNAPSHOT
TABLE 88. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: PRODUCT SEGMENTS
TABLE 89. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: PRODUCT PORTFOLIO
TABLE 90. AMWAY CORP.: KEY EXECUTIVES
TABLE 91. AMWAY CORP.: COMPANY SNAPSHOT
TABLE 92. AMWAY CORP.: PRODUCT SEGMENTS
TABLE 93. AMWAY CORP.: PRODUCT PORTFOLIO
TABLE 94. BAYER AG: KEY EXECUTIVES
TABLE 95. BAYER AG: COMPANY SNAPSHOT
TABLE 96. BAYER AG: PRODUCT SEGMENTS
TABLE 97. BAYER AG: PRODUCT PORTFOLIO
TABLE 98. BASF SE: KEY EXECUTIVES
TABLE 99. BASF SE: COMPANY SNAPSHOT
TABLE 100. BASF SE: PRODUCT SEGMENTS
TABLE 101. BASF SE: PRODUCT PORTFOLIO
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
